Role of HGF in epithelial–stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ
Open Access
- 12 September 2013
- journal article
- Published by Springer Science and Business Media LLC in Breast Cancer Research
- Vol. 15 (5), R82
- https://doi.org/10.1186/bcr3476
Abstract
Basal-like and luminal breast cancers have distinct stromal–epithelial interactions, which play a role in progression to invasive cancer. However, little is known about how stromal–epithelial interactions evolve in benign and pre-invasive lesions.This publication has 61 references indexed in Scilit:
- Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitorsNature, 2012
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretionNature, 2012
- Human primary ductal carcinoma in situ (DCIS) subtype‐specific pathology is preserved in a mouse intraductal (MIND) xenograft modelThe Journal of Pathology, 2011
- Stage-dependent regulation of mammary ductal branching by heparan sulfate and HGF-cMet signalingDevelopmental Biology, 2011
- Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progressionNature Medicine, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancerProceedings of the National Academy of Sciences of the United States of America, 2009
- Demystifying the Effects of a Three‐Dimensional Microenvironment in Tissue MorphogenesisPublished by Elsevier BV ,2007
- The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expressionMolecular Oncology, 2007
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerThe New England Journal of Medicine, 2002